Stock comparison

RVTYvsWST

Revvity IncvsWest Pharmaceutical Services Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

RVTY

Revvity Inc

$87.15

-13.27%

Life Sciences Tools & Services$9.8BNYSE
WST

West Pharmaceutical Services Inc

$309.7

+16.24%

Life Sciences Tools & Services$17.0BNYSE

60-day price, rebased to 100

RVTY -21.58% · WST +34.00%

Round-by-round

RVTY 1·WST 4· 1tie
EdgeRVTY

Valuation upside

-45.20% vs -53.90% to DCF fair value

EdgeWST

Balance-sheet strength

Altman Z 2.32 vs 12.33

EdgeWST

Fundamental quality

Piotroski 5.00 vs 7.00 (of 9)

Tie

Growth + margins

Rule-of-40 21.50 vs 21.50

EdgeWST

60-day momentum

-21.58% vs +34.00% price return

EdgeWST

Market-cap liquidity

$9.8B vs $17.0B

Verdict

Across6categories,WSTtakes the edge with4wins to1 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onRVTYorWST

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more